Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$68.31 USD

68.31
403,799

+0.94 (1.40%)

Updated Sep 18, 2025 12:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 245)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Sriparna Ghosal headshot

3 MedTech Stocks to Rebound After Coronavirus-Led Recoil

by Sriparna Ghosal

As the coronavirus chaos continues to rise, MedTech firms have been witnessing a spike in demand for protective respiratory equipment.

Zacks Equity Research

Here's Why You Should Retain Henry Schein (HSIC) Stock Now

by Zacks Equity Research

Investor confidence continues to be high in Henry Schein (HSIC) stock, courtesy of solid prospects.

Zacks Equity Research

Henry Schein (HSIC) Q4 Earnings and Revenues Top Estimates

by Zacks Equity Research

Henry Schein (HSIC) registers solid performance by each of its key operating businesses in Q4.

Zacks Equity Research

Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings?

by Zacks Equity Research

Consistent contribution from Henry Schein One is likely to have benefited Henry Schein's (HSIC) Q4 performance.

Sreyoshi Mukherjee headshot

Bleak Outlook for Medical Dental Supplies Industry

by Sreyoshi Mukherjee

Despite digital dentistry and AI being dominant market trends, near-term prospects of the Dental industry look dull.

Zacks Equity Research

Why Is Henry Schein (HSIC) Up 0.8% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

by Zacks Equity Research

Patterson Companies (PDCO) has likely gained from strength in Animal Health segment in the fiscal second quarter.

Zacks Equity Research

Henry Schein to Showcase New Dental Offerings at GNYDM

by Zacks Equity Research

Henry Schein's (HSIC) suite of solutions, education, & social media activity featuring dental industry leaders to enable dental professionals to explore new options revolutionizing digital dentistry.

Zacks Equity Research

Henry Schein (HSIC) Q3 Earnings Top Estimates, Revenues Lag

by Zacks Equity Research

Henry Schein (HSIC) registers solid performance across its key operating businesses in Q3.

Zacks Equity Research

Henry Schein (HSIC) Q3 Earnings Top Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 4.65% and -0.51%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Medical Products' Earnings Roster for Nov 5: BDX, ZBH & More

by Urmimala Biswas

Encouraging growth in the emerging markets despite the ongoing Sino-US trade tensions is likely to favor revenues in the medical products space this earnings season.

Zacks Equity Research

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Should You Buy? (Revised)

by Zacks Equity Research

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Can Dental Growth Drive Henry Schein's (HSIC) Q3 Earnings?

by Zacks Equity Research

The robust performance of the Primescan system in Europe and the United States is expected to have contributed to Henry Schein's (HSIC) top line during Q3.

Zacks Equity Research

Henry Schein (HSIC) Expected to Beat Earnings Estimates: Should You Buy?

by Zacks Equity Research

Henry Schein (HSIC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

What's in the Offing for Stryker's (SYK) Earnings in Q3?

by Zacks Equity Research

Solid segmental performances at Medsurg, Orthopaedic and Neurotechnology & Spine and an upbeat third quarter 2019 view are likely to have contributed to Stryker's (SYK) Q3 earnings.

Zacks Equity Research

Why Henry Schein (HSIC) Could Beat Earnings Estimates Again

by Zacks Equity Research

Henry Schein (HSIC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

Here's Why You Should Retain Henry Schein (HSIC) Stock Now

by Zacks Equity Research

Investor confidence is still high on Henry Schein (HSIC), thanks to solid prospects.

Sreyoshi Mukherjee headshot

Dental Supplies Industry's Near-Term Outlook Looks Bright

by Sreyoshi Mukherjee

With popular trends of digital dentistry and robotics gaining momentum, near-term prospects of the dental industry look promising.

Zacks Equity Research

Here's Why You Should Retain Patterson Companies (PDCO) Now

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.

Zacks Equity Research

Paylocity, Macy's, Henry Schein, DENTSPLY and Patterson Companies highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Paylocity, Macy's, Henry Schein, DENTSPLY and Patterson Companies highlighted as Zacks Bull and Bear of the Day

Zacks Equity Research

Why Is Henry Schein (HSIC) Down 2.2% Since Last Earnings Report?

by Zacks Equity Research

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Sriparna Ghosal headshot

3 Best Dental Stocks to Keep An Eye On

by Sriparna Ghosal

Dental practice management software helps dental businesses run smoothly by ensuring safe storage and easy access of critical information.

Zacks Equity Research

Henry Schein Expands SolutionsHub With CueSquared MobilePay

by Zacks Equity Research

The platform is expected to augment Henry Schein's (HSIC) patient revenues, accelerate payments and curb collection costs.

Zacks Equity Research

What's in Store for Patterson Companies (PDCO) in Q1 Earnings?

by Zacks Equity Research

Patterson Companies (PDCO) expects Dental and Animal Health arms to boost first-quarter fiscal 2020 results.

Zacks Equity Research

Should Value Investors Pick Henry Schein (HSIC) Stock Now?

by Zacks Equity Research

Let's see if Henry Schein (HSIC) stock is a good choice for value-oriented investors right now from multiple angles.